A B‐Raf V600E gene signature for melanoma predicts prognosis and reveals sensitivity to targeted therapies
Sign Up to like & getrecommendations! Published in 2022 at "Cancer Medicine"
DOI: 10.1002/cam4.4491
Abstract: B‐Raf V600E mutations account for about half of all skin cutaneous melanoma cases, and patients with this mutation are sensitive to BRAF inhibitors. However, aberrations in other genes in the MAPK/ERK pathway may cascade a… read more here.
Keywords: prognosis; sensitivity; melanoma; signature ... See more keywords